Exoskeleton-Assisted Therapy for Stroke
Trial Summary
What is the purpose of this trial?
Stroke is the leading cause of adult-onset disability, and affects 15,000 Veterans each year. Successful rehabilitation and recovery following a stroke requires therapy including repetitive task training. However, repetitive task training can be draining for both the clinician and the patient as it requires the participant to complete many repetitions of the same task and those repetitions can be difficult to accomplish with appropriate technique. Robot-mediated repetitive task training has the potential to facilitate the clinical delivery of proven rehabilitation programs to Veterans in need and recently a new exoskeleton has been developed, called Harmony, which can deliver bimanual 3D arm therapy. The investigators propose to develop and test two novel controllers', synergy avoidance and task assistance, that use promising neurological basis for training to facilitate repetitive task training while ensuring correct movement patterns in acute and sub-acute stage stroke patients. This has the potential to improve Veterans' activities of daily living and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Exoskeleton-Assisted Therapy for Stroke treatment?
Research shows that robotic exoskeletons can help improve movement and walking in stroke patients by providing necessary assistance while encouraging active participation. Studies have demonstrated improvements in motor control and daily activities, suggesting that exoskeletons can be a promising tool for stroke rehabilitation.12345
Is exoskeleton-assisted therapy safe for humans?
How does the Exoskeleton-Assisted Therapy for Stroke differ from other treatments for stroke recovery?
The Exoskeleton-Assisted Therapy for Stroke is unique because it uses a robotic exoskeleton to provide targeted assistance to patients, allowing them to perform movements with minimal help, which encourages active participation and potentially faster recovery. This approach contrasts with traditional therapies that may not offer the same level of personalized, adaptive support and motivation through interactive elements like virtual reality games.1451011
Research Team
Brittney C Muir, PhD
Principal Investigator
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Eligibility Criteria
This trial is for stroke survivors over 18 who fit within the Harmony exoskeleton's size limits. Participants should have moderate to severe upper limb impairment, as measured by a specific score, and must have had their stroke recently (1 week to 6 months prior). Those with unstable health conditions, severe joint pain in the limbs, cognitive or language barriers, multiple strokes, seizures or significant communication issues cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Early Testing
Up to 5 participants testing the SA controller in one visit
Treatment
Participants complete high repetitions of reaching tasks once per day while wearing the Harmony exoskeleton for three weeks
Follow-up
Participants are monitored for changes in joint coordination and compensatory strategies after the intervention
Treatment Details
Interventions
- SA controller
- TA controller
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor